India raises concerns over FDA actions on domestic drug firms


The matter came up during a meeting here between Commerce and Industry Minister Anand Sharma and USFDA Commissioner Margaret A Hamburg.NEW DELHI: India today raised serious concerns over the USFDA’s audit inspections of Indian pharma companies and ‘disproportionate penalties’ in some instances and said it would submit a discussion document on the issues to the US.

The matter came up during a meeting here between Commerce and Industry Minister Anand Sharma and US Food and Drug Administration (USFDA) Commissioner Margaret A Hamburg.

“We are going to give a non-paper (to the US) overall on some of our concerns, when it comes to duration for the registration process for the filing,” Sharma told reporters after the meeting. Read more

Source: http://economictimes.indiatimes.com/

Advertisements

Tagged as: , , , , , , , , , , , , , , , , , , ,

Categorised in: Pharma & Healthcare, Sector News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: